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INTRODUCTION:  Amyloid  goiter  (AG)  is  characterized  by  enlargement  of  the  thyroid  gland as a  result  of
extensive  amyloid  deposition  in a bilateral  and  diffuse  manner.
PRESENTATION  OF  CASE:  A  58-year-old  male  patient  was  diagnosed  of  Crohn’s  Disease  (CD).  He was
admitted  to  our  clinic  with  complaint  of  respiratory  distress  and  rapid  growth  swelling  in  the  neck.
Ultrasound  examination  revealed  huge  multinodular  goiter  on  both  sides  of thyroid  gland.  We  performed
bilateral  total  thyroidectomy.  Pathological  evaluation  revealed  AG.
DISCUSSION:  Amyloid  leads  to degeneration  in  tissues,  thereby  disrupts  the  function  of the  relevant
organs.  It  is important  to distinguish  AG  from  other  reasons  of  goiter,  particularly  thyroid  medullary
cancer  that  can  cause  amyloid  deposition  in  thyroid  gland.  Secondary  amyloidosis  frequently  involvesmyloid goiter thyroid  gland  at microscopic  level,  but rarely  causes  goiter.  An  analysis  of current  literature  revealed
that  only  few  cases  of AG  occurred  secondary  to CD.  Herein  we  presented  a  case  of AG who has  rapidly
growing  goiter  that associated  with  CD.
CONCLUSION:  AG  must  be kept  in mind  in case  of  rapidly  growing  goiter,  especially  in  patients  with
chronic  inﬂammatory  bowel  diseases.
© 2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Amyloid is an amorphous and proteinaceous material that accu-
ulates in tissue and causes amyloidosis.1 It may  effect a single
rgan or cause systemic involvement.2,3 Amyloidosis is classiﬁed
s primary or secondary. The latter accompany to neoplasms or
hronic inﬂammatory diseases. “Serum Amyloid A” is an acute
hase reactant that accumulates in various organs of patients
ith secondary amiloidosis.1,4,5 In 1948, Olson et al. reported
he ﬁrst case of secondary amyloidosis caused by Crohn’s disease
CD).6 Amyloid accumulates in thyroid gland in case of amyloid-
sis or medullary thyroid cancer. Amyloid depots exist in thyroid
land at microscopic level up to 50–80% in patients with systemic
myloidosis.7 These patients are mostly euthyroid and usually
resent with pressure symptoms due to rapidly growing thyroid
land.8–10 Herein, we reported a very rare cause of AG, which devel-
ped during the course of CD.
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210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical A
http://creativecommons.org/licenses/by-nc-nd/3.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Presentation of case
A 58-year-old male patient with intermittent diarrhea for
about 20 years, endoscopic biopsy performed to conﬁrm the CD.
Symptoms were treated with budesonide and 5-aminosalicylic
acid orally. After six months, therapy was  discontinued because
of drug intolerance. Afterwards, patient was  admitted to hospi-
tal with rapidly growing swelling of neck, respiratory distress,
dyspnea and fatigue. Physical examination revealed rather large
thyroid gland as multi-nodular pattern on both lobes (Fig. 1).
Thyroid function tests were all within the normal in range.
Ultrasonography (USG) examination revealed that the size of
the left lobe was  137 mm × 103 mm × 35 mm and right was
119 mm × 76 mm × 43 mm.  Thyroid tissue was  detected as diffuse
heterogeneous and micro-nodular pattern. Multiple nodules were
also detected bilaterally with the largest of them is measured
19 mm in size. Cervical and thoracic computed tomography exam-
ination showed an excessive growth of the thyroid gland and its
lower boundaries extended to the mediastinum. Thyroid scintigra-
phy showed a heterogeneous distribution of radioactivity in both
lobes. Fine-needle aspiration biopsy (FNAB) revealed a benign thy-
roid tissue. We  performed total thyroidectomy. Thyroid tissue
was extremely soft and fragile, macroscopically. And right lobe of
the thyroid gland was  12 cm × 7.5 cm × 4.5 cm and left lobe was
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. The appearance of multinodular goiter in the neck.
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FFig. 2. Macroscopic aspect of thyroidectomy specimen.
4 cm × 10.5 cm × 3.5 cm in size (Fig. 2). There were nodular and
iffuse areas in the cross-sectional samples, and the microscopic
valuation revealed extracellular amorphous proteinaceous mate-
ial widely deposited in the stroma with Hematoxylin and Eosin
H&E) staining (Fig. 3). Crystal violet and Congo red also showed
 positive staining (Figs. 4 and 5). There were no malignancies
r inﬂammatory diseases detected, unless CD. Therefore we  con-
ider the patient as an amyloid goiter due to CD. Patient discharged
econd day after operation, without any complications. Amyloid
eposition was not observed in biopsy specimen taken during
olonoscopy. There were no recurrence or other organ involvement
ssociated with amyloidosis after 24-month follow-up.
. DiscussionAmyloid is a ﬁbrillar protein that accumulates in various organs
nd disrupts the function of these organs.11 It is determined
icroscopically as an intercellular and semi-transparent material.
ig. 3. Extracellular amorphous material is deposited widely in the stroma (H&E).Fig. 4. Crystal violet showed a positive staining for amyloid.
Amyloid has many subtypes that two  of them are the major.
Despite the similarity in their staining patterns, amyloid is not a
single chemical entity. Therefore, it will be more appropriate to
describe amyloidosis as a heterogeneous group of diseases char-
acterized by ﬁbrillar protein deposits that have similar staining
characteristic.12,13
Amyloidosis is classiﬁed as primary and secondary. In pri-
mary amyloidosis, amount of monoclonal plasma cells increase
in bone marrow, similarly immunoglobulin light chains (AL type)
increase in the affected tissue. Secondary amyloidosis accompanies
malignancies or chronic inﬂammatory diseases such as tubercu-
losis, rheumatoid arthritis, ankylosing spondylitis, cystic ﬁbrosis,
bronchiectasis and inﬂammatory bowl disease.6 Approximately,
75% of patients with secondary amyloidosis that accompanying to
CD are male, just as our case.14–16 It was reported in autopsy stud-
ies that amyloid deposition is found in the thyroid gland of 50%
of primary amyloidosis and 80% of secondary amyloidosis.7,8,17 AG
is observed in about 0.04% of cases with primary systemic amy-
loidosis, and these patients have poorer prognosis.9,18 Symptoms
depend on the involved organ.
Amyloid deposition in thyroid gland was ﬁrst published by
Rokitansky in 1855. Beckmann reported a clinically visible thy-
roid enlargement due to amyloidosis in 1858.19,20 The association
of CD with amyloidosis is a rare entity that ﬁrst time reported
by Moschkowitz in 1936.14,15,21 Afterwards, Olson et al. reported
a case of secondary amyloidosis related to CD, in 1948.6 Since
then, some similar cases and reviews reported by various authors,
between 1982 and 2009.22,23 Greenstein et al. investigated and
reported 3050 patients with inﬂammatory bowel disease in 1992.
According to this report, 22 (1.29%) of 1708 patients with CD were
complicated by secondary amyloidosis.24,25 Nevertheless AG is very
rare in this group of patients. So far, only few AG cases secondary
to CD were reported in the literature.6,26–29
Fig. 5. Congo red showed a positive staining for amyloid.
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Earlier articles suggest that thyroid gland tends to enlarge
apidly within few weeks or months, in patients with AG.11 Rapidly
rowing thyroid gland due to amyloid involvement may  cause com-
ressive symptoms such as dyspnea, and dysphagia, as in our case.
n case of rapidly growing thyroid gland AG should also be come to
ind such as anaplastic cancer and lymphoma. The structure of thy-
oid gland is usually in form of diffuse goiter in patients with AG, but
ometimes cystic or nodule-like solid lesions may  coexisted.11,22 In
ur patient, it was remarkable that thyroid tissue was excessively
oft and fragile. Sometimes AG may  be clinically asymptomatic
nd rarely present with thyroiditis-like condition.10,30 Thyroid
unction tests are determined generally in normal range, even in
atients with wide thyroid involvement. Hypothyroidism or hyper-
hyroidism are seen less frequently.10,22 In our case, free T3, free T4
nd TSH levels were all within the normal in range. Kimura et al.
eported that serum thyroglobulin level could be higher than nor-
al  range in patients with AG, due to destruction of thyroid follicles
y amyloid deposition.7
Meyers and Janowits reported that 29.4% of patients with CD
ad renal amyloidosis at autopsy, but only 1% was  diagnosed dur-
ng lifetime.31 Most of the cases with secondary amyloidosis are
iscovered by proteinuria or nephrotic syndrome due to renal
myloidosis.32 Renal involvement is frequently observed in amy-
oidosis related to CD, and diagnosed with pathological veriﬁcation.
n our patient, blood urea nitrogen and creatinine levels were all
ithin the normal in range.
Amyloid disrupts normal histological pattern of thyroid
land by inﬁltrating the parenchyma. Fine needle aspiration
tests for chronic inﬂammatory diseases should be made in patients
with AG. It may  be suitable to examine the thyroid gland and ana-
lyze the serum thyroglobulin level, in order to detect secondary
amyloidosis at an early stage in patients with CD.
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Key learning pointnd, s
1
1
1ytology (FNAC) is a safe and effective procedure for the diagnosis
f thyroid amyloidosis. FNAC allows exclusion of thyroid malig-
ancies such as medullary thyroid carcinoma. However it may  be
nconclusive due to insufﬁcient cellular material. Therefore, deﬁni-
ive diagnosis of AG generally rests on the histologic evaluation
f surgical specimens, as in our case.33 Microscopic examina-
ion generally shows extracellular amorphous, eosinophilic, and
roteinaceous material in patients with amyloidosis. Focal lym-
hocytic thyroiditis and foreign body reaction commonly coexist
ith the amyloid inﬁltration.34 Amyloid has positive stainining
ith Congo red, Thioﬂavin T and Crystal violet. Congo red staining
as a diagnostic sensitivity of 70–90% with FNAC from a symptom-
iving organ.34–36 Amyloid material appears as cherry red and it
lso shows apple-green birefringence when observed with a polar-
zing microscope.37
. Conclusion
Existence of amyloid deposition in thyroid gland without sys-
emic involvement is very rare clinical condition that can observe
n course of CD. Analysis of current literature is revealed that only
ew cases of AG are reported related to CD. As a result, in case of
apidly growing neck mass, AG should be taken into consideration
• In case of rapidly growing goiter, AG must be kept in mior the differential diagnosis such as anaplastic thyroid carcinoma
nd lymphoma. Nevertheless, cellular morphology must be exam-
ned carefully for differential diagnosis of medullary carcinoma in
ase of existence of amyloid deposition in thyroid gland. Screening
1
1uch as anaplastic cancer and lymphoma of thyroid gland.
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